Catalyst Pharmaceuticals
Angela Lavely has a strong background in sales and leadership roles in the pharmaceutical industry. Angela is currently working as an Area Business Director at Catalyst Pharmaceuticals, Inc. since May 2023. Prior to this, they had a successful tenure at Eisai US, where they held positions such as Senior Specialty District Sales Manager and Senior District Sales Manager from December 2019 to May 2023. From May 2017 to December 2019, Angela worked at Sanofi as an Area Business Leader. Before that, they held various positions at Sanofi, including Hospital & LTC Sales Professional, Specialty Sales Representative, and District Sales Manager. Angela'scareer started at Meda in 2002, where they worked as a District Sales Manager.
Angela Lavely attended Georgia Southwestern State University from 1988 to 1993, where they obtained a Bachelor of Science degree in Biology.
This person is not in the org chart
This person is not in any offices
Catalyst Pharmaceuticals
2 followers
Catalyst Pharmaceuticals is a commercial-stage, patient-centric biopharmaceutical company focused on in-licensing, developing, and commercializing novel high-quality medicines for patients living with rare diseases. With exceptional patient focus, Catalyst is committed to developing a robust pipeline of cutting-edge, first- or best-in-class medicines for other rare diseases. Catalyst's New Drug Application for FIRDAPSE® (amifampridine) Tablets 10 mg for the treatment of adults with Lambert-Eaton myasthenic syndrome ("LEMS") was approved in 2018 by the U.S. Food & Drug Administration ("FDA"), and FIRDAPSE is commercially available in the United States as a treatment for adults with LEMS. Further, Canada's national healthcare regulatory agency, Health Canada, has approved the use of FIRDAPSE for the treatment of adult patients in Canada with LEMS.